Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise

The RAND appropriateness method was used to explore the relevance of risk factors for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). A total of, 12 international experts assessed the appropriateness of various treat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Prostate cancer and prostatic diseases 2005-12, Vol.8 (4), p.369-374
Hauptverfasser:	Speakman, M, Batista, J, Berges, R, Chartier-Kastler, E, Conti, G, Desgrandchamps, F, Dreikorn, K, Lowe, F, O'Leary, M, Perez, M, Trachtenberg, J, Tubaro, A, Meesen, B, Smets, L, Stoevelaar, H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic receptors Antagonists Biomedical and Life Sciences Biomedicine Cancer Research Disease Progression Flow velocity Genital diseases Health risks Health services Humans Hyperplasia Male Patients Prostate Prostatic Hyperplasia - complications Prostatic Hyperplasia - pathology Prostatic Hyperplasia - therapy Reductases Risk analysis Risk assessment Risk Factors Signs and symptoms Surgery Urinary tract Urogenital system Urologic Diseases - complications Urologic Diseases - pathology Urologic Diseases - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!